Purple Strategies
Constituents on a crowded main street, campaign buttons in hand

Win the argument before the vote

Campaign-style issue advocacy

Coalitions, grassroots, and Beltway pressure — firing in sequence.

Start the campaign

The stakes

A vote, a rule, a ruling is coming — and the side that shaped opinion first usually wins it. Most organizations show up to the fight after the narrative has already hardened. By then, persuasion is expensive and the votes are spoken for.

Why Purple runs issue advocacy differently

01

Insights-driven strategy

We start from what moves the public, not from a press plan. Original research finds the argument that already lives in people’s values — then we build the campaign on it.

02

Values-based reframing

The right frame changes the whole fight. We find the value a broad coalition already shares — and turn a narrow, technical dispute into a story both parties can vote for.

03

The right messenger, every moment

The most persuasive voice is rarely your own. We recruit and ready the validators an audience already trusts — and put the right one forward at the right moment, on both sides of the aisle.

The proof

Campaigns we built, and the outcomes they moved.

A patient and an advisor at the pharmacy counter

PhRMA · The “middlemen” campaign

Reframed PBMs as “middlemen” — and made reform a bipartisan vote.

Drugmakers Have Spent Millions Targeting ‘Middlemen’ — and It’s Paying Off

The Wall Street Journal

Outcome

The House passed reform with 83% of Democrats and more than 80% of Republicans.

02United for Cures

A patient-led coalition defending American medical research.

Outcome

A proposed 40% cut was rejected; Congress set NIH funding at $48.7 billion.

03America’s leading research universities

Made proposed research cuts politically intolerable.

Outcome

Tied research funding to jobs, safety, and national competitiveness — with clear winners and losers.

04A leading HIV-innovation company

A grassroots coalition reversed a federal move to strip HIV therapies from protected drug classes.

Outcome

The protected-class listing held; the policy was turned back.

05A top-five pharmaceutical company

Made Alzheimer’s a must-act national priority.

Outcome

Built the environment that met an FDA-approved therapy in 2024.

Bipartisan by design

Both sides of the aisle — hence the purple. Veteran operatives from winning Democratic and Republican campaigns at the same table.

The fights we’re in

PBM reform and academic research; energy transmission and childhood vaccines; defense policy, trade, and tariffs — wherever a policy fight runs hot.

Senior partners at the table

The people who win your campaign are the people who run it — not a pitch team you never see again.

Start the campaign

Tell us what you’re fighting for

A senior partner reads every inquiry. You’ll hear back from someone who has run a campaign like yours — not a form letter.

“Both sides of the aisle — hence the purple.”

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Purple Strategies

Washington, DC · Chicago  ·  © 2026 Purple Strategies. All Rights Reserved.  Privacy Policy.